Vireo Growth Inc.

https://www.vireogrowth.com

Vireo Growth Inc. is a cannabis company focused on the cultivation, manufacturing, processing, and distribution of both medical and adult-use cannabis products. The company's mission is to ensure safe access, deliver quality products, and provide value to its customers, while also actively supporting local communities through participation and restorative justice programs. Headquartered in Minneapolis, Minnesota, Vireo Growth Inc. operates across various states in the U.S.

The company's operations encompass cultivation, manufacturing, wholesale, and retail business lines, offering a diverse portfolio of cannabis products including flower, pre-rolls, vaporizers, concentrates, edibles, and tinctures. Vireo Growth Inc. distributes its products through an extensive network of retail dispensaries and third-party distributors, with a presence in states such as Maryland, Minnesota, Missouri, Nevada, New York, and Utah. The company also manages a portfolio of brands including Vireo Spectrum, Green Goods, Boundary Waters, HiColor, Kings & Queens, 1937, Small A$$ Buds, and Dr. Westwater.

Recent strategic initiatives highlight Vireo Growth Inc.'s aggressive expansion and market positioning. In April 2026, the company announced an agreement to acquire Florida-based FLUENT Corp. in an all-stock transaction, a move expected to significantly expand its footprint in Florida's medical cannabis market. Other notable developments include a California retail joint venture with Glass House Brands and the acquisition of The Hawthorne Gardening Company. Leadership includes John Mazarakis as CEO and Co-Executive Chairman, and Kyle Kingsley, M.D., as Founder and Co-Executive Chairman.

Latest updates

Vireo Acquires Fluent in All-Stock Deal, Bets on Florida Scale

Event summary

  • Vireo Growth Inc. is acquiring FLUENT Corp. in an all-stock transaction, with FLUENT shareholders receiving 0.0705359 shares of Vireo for each FLUENT share.
  • The deal is expected to significantly expand Vireo’s presence in Florida, adding approximately 74 stores and 144,000 square feet of cultivation/production space.
  • FLUENT generated approximately $71.5 million in revenue from its Florida operations in 2025.
  • FLUENT is undertaking a pre-closing business restructuring, including potential asset divestitures and cost reductions.
  • Approximately $30 million of FLUENT’s existing debt will be equitized and exchanged for FLUENT shares, which will later convert to Vireo shares.

The big picture

This acquisition reflects a broader trend of consolidation within the cannabis industry, where scale and capital access are increasingly vital for survival. Vireo's move to acquire FLUENT demonstrates a strategic focus on the Florida market, which has a limited license structure that rewards larger operators. The deal also highlights the ongoing challenge of navigating regulatory hurdles and the importance of operational efficiency in a competitive landscape.

What we're watching

Regulatory Approval
The deal's success hinges on securing regulatory approvals in each market, which could be delayed or denied given ongoing federal restrictions on cannabis businesses.
Integration Risk
Successfully integrating FLUENT’s operations and culture into Vireo’s existing structure will be critical to realizing anticipated synergies and avoiding operational disruptions.
Florida Market
The competitive landscape in Florida’s medical cannabis market will determine whether the combined entity can maintain its leading position and justify the acquisition price.

Vireo, Glass House Form California Retail Joint Venture

Event summary

  • Vireo Growth and Glass House Brands are forming a 50/50 joint venture to consolidate California cannabis retail operations.
  • Vireo contributes its twelve dispensaries (acquired from Eaze), while Glass House contributes eleven.
  • The joint venture will operate under the leadership of Cory Azzalino (formerly Vireo's President of California).
  • A preferential supply agreement will be in place with Glass House, leveraging its production scale.
  • Vireo has an option to acquire Glass House’s equity interest after five years, with a reciprocal put right for Glass House.

The big picture

This joint venture represents a strategic move to consolidate California's fragmented cannabis retail market, which remains the largest legal market globally. By combining Vireo’s retail reach and delivery capabilities with Glass House’s production scale and brand equity, the venture aims to navigate California’s challenging pricing environment and expand distribution. The deal underscores the ongoing trend of consolidation within the cannabis industry as companies seek scale and efficiency to compete.

What we're watching

Execution Risk
Integrating disparate retail operations and delivery infrastructure from Eaze presents significant operational challenges that could impact profitability and market share gains.
Regulatory Headwinds
California's cannabis regulatory landscape remains complex and subject to change, potentially impacting the joint venture’s ability to expand and maintain competitive pricing.
Governance Dynamics
The five-year option for Vireo to acquire Glass House’s stake introduces a potential conflict of interest and could influence the joint venture’s long-term strategic direction.

Vireo Acquires Hawthorne Gardening in Share-Heavy Deal

Event summary

  • Vireo Growth Inc. acquired The Hawthorne Gardening Company from The Scotts Miracle-Gro Company.
  • The deal consideration includes 213 million shares of Vireo (valued at ~$83.7M as of April 7, 2026) and 80 million warrants.
  • Good Dog Holdings LLC, the entity acquiring the shares, now holds approximately 14% of Vireo, with potential to increase to 19% with warrant exercise.
  • Hawthorne brings ~$110 million in combined cash and net working capital to Vireo's balance sheet.

The big picture

Vireo’s acquisition of Hawthorne, while bolstering its balance sheet, represents a significant bet on the indoor gardening market and a substantial equity stake taken by Good Dog Holdings. The deal’s structure, heavily reliant on share issuance, raises questions about Vireo’s long-term capital structure and shareholder value. This move highlights the ongoing consolidation within the cannabis ancillary space as larger players seek to expand their product offerings and market reach.

What we're watching

Share Dilution
The significant share issuance to Good Dog Holdings will dilute existing shareholders and warrants close scrutiny of Vireo’s ability to generate returns justifying the increased share count.
Integration Risk
Hawthorne’s operational integration into Vireo’s platform presents execution risk, particularly concerning synergies and cost efficiencies as claimed by management.
Governance Shift
The appointment of Chris Hagedorn to Vireo’s board signals a potential shift in strategic direction and warrants observation of his influence on the company's future decisions.

Vireo Acquires Eaze, Expanding Footprint into Key Cannabis Markets

Event summary

  • Vireo Growth Inc. has completed its acquisition of Eaze Inc. on April 1, 2026.
  • The acquisition expands Vireo’s operations to 10 states, encompassing over 160 dispensaries and 800,000 sq. ft. of cultivation/production.
  • Eaze adds California and Florida to Vireo’s market presence, and increases retail locations in Colorado by 15.
  • Cory Azzalino, formerly CEO of Eaze, will lead Vireo’s California business.

The big picture

This acquisition signals a continued trend of consolidation within the fragmented cannabis industry, as established players seek to gain scale and market share in key states. Vireo’s entrance into California and Florida, two of the largest cannabis markets in the US, positions the company to compete more effectively, but also exposes it to increased regulatory and competitive pressures. The deal’s success will depend on Vireo’s ability to leverage Eaze’s delivery infrastructure and retail expertise to drive profitability and navigate the evolving legal landscape.

What we're watching

Integration Risk
The success of this acquisition hinges on Vireo’s ability to effectively integrate Eaze’s operations and technology, particularly in the highly competitive California market, and avoid operational disruptions.
Regulatory Headwinds
Continued uncertainty surrounding federal cannabis legalization and potential changes to state-level regulations could impact Vireo’s ability to capitalize on its expanded footprint and Eaze’s delivery platform.
Execution Risk
The performance of Cory Azzalino and his team in scaling Vireo’s California business will be a key indicator of the acquisition’s long-term value creation and Vireo’s overall strategic direction.

Vireo Transfers Shares to Escrow as PharmaCann Management Agreement Begins

Event summary

  • Vireo Growth Inc. and PharmaCann Inc. initiated a Management Services Agreement (MSA) on March 22, 2026, as part of a previously announced Asset Purchase Agreement (APA).
  • Vireo has placed 90,740,741 subordinate voting shares into escrow with Odyssey Trust Company.
  • The escrowed shares will be released upon the completion of Vireo’s acquisition of PharmaCann’s Colorado retail assets, expected in Q2 2026.
  • The APA and MSA were initially announced on December 16, 2025.

The big picture

This agreement represents a strategic move for Vireo to expand its retail footprint in Colorado, a key market for cannabis sales. The MSA provides operational continuity while the acquisition awaits regulatory clearance, but also introduces a period of shared management and potential integration challenges. The escrow of a significant share count suggests Vireo is prioritizing deal certainty, but also signals a degree of risk associated with the acquisition's finalization.

What we're watching

Regulatory Approval
The closing of the asset acquisition remains contingent on regulatory approval, which could introduce delays or require modifications to the deal terms.
Execution Risk
Vireo’s ability to effectively manage PharmaCann’s assets during the interim period will be crucial for ensuring a smooth transition and maximizing the value of the acquisition.
Shareholder Sentiment
The substantial number of shares placed in escrow could create downward pressure on Vireo’s stock price if investors perceive the acquisition as risky or overly dilutive.

Vireo to Acquire Hawthorne Gardening in Share-Based Deal

Event summary

  • Vireo Growth Inc. is acquiring The Hawthorne Gardening Company from ScottsMiracle-Gro via a non-binding Memorandum of Understanding.
  • The deal structure involves Vireo issuing 206 million subordinate voting shares and a warrant for 80 million shares, alongside $35 million in cash and $50 million in net working capital.
  • ScottsMiracle-Gro EVP Chris Hagedorn is slated to join Vireo’s Board of Directors following shareholder approval.
  • The transaction is expected to close during the second quarter of 2026, pending definitive agreements and regulatory approvals.

The big picture

Vireo's acquisition of Hawthorne represents a strategic move to expand its presence in the indoor gardening supply chain, a sector experiencing significant growth alongside the broader cannabis industry. The share-based deal, while offering Vireo access to Hawthorne's established distribution network and brand recognition, also carries the risk of substantial shareholder dilution. The appointment of a ScottsMiracle-Gro executive to Vireo’s board suggests an attempt to ensure a smooth transition and knowledge transfer, but also introduces potential governance considerations.

What we're watching

Share Dilution
The significant share issuance raises concerns about potential dilution for existing Vireo shareholders, particularly given the current share price and the warrant component.
Integration Risk
Successfully integrating Hawthorne's operations and product lines with Vireo's existing business will be crucial, and any missteps could hinder the anticipated synergies.
Regulatory Approval
The deal's reliance on regulatory approvals, including from the Canadian Securities Exchange, introduces uncertainty and potential delays, which could impact the timeline and overall value of the acquisition.

Vireo Acquires Schwazze Assets, Eyes Colorado/New Mexico Retail Expansion

Event summary

  • Vireo Growth Inc. completed the acquisition of assets from Schwazze, including 24 dispensaries in Colorado, 21 in New Mexico, and manufacturing facilities in both states.
  • The acquisition was priced at an assumed share price of $0.661 per share.
  • Forrest Hoffmaster will serve as CEO of Vireo’s Colorado and New Mexico operations, while Justin Dye assumes the role of Chairman for those businesses.
  • Vireo estimates a pro forma EBITDA multiple of under 4x for the acquired assets.

The big picture

Vireo’s acquisition of Schwazze assets represents a strategic bet on the Colorado and New Mexico cannabis markets, aiming to build a scaled retail presence. The sub-4x EBITDA multiple suggests a depressed market valuation, potentially reflecting broader industry headwinds and investor caution. Vireo's stated goal of expanding to 75 dispensaries signals an aggressive growth strategy, but will require significant capital and regulatory approvals.

What we're watching

Execution Risk
The integration of 24 Colorado and 21 New Mexico dispensaries presents significant operational challenges, and Vireo’s success hinges on effectively combining disparate retail networks.
Regulatory Headwinds
The stated ambition to reach 75 dispensaries in Colorado and New Mexico is contingent on continued favorable regulatory developments and licensing availability, which remain uncertain.
Governance Dynamics
The appointment of Justin Dye and Forrest Hoffmaster suggests a shift in leadership and strategic direction, and their ability to align with Vireo’s existing management will be crucial for long-term success.

Vireo Growth's Revenue Surge Masks Integration Risks as Acquisitions Pile Up

Event summary

  • Vireo Growth reported Q4 GAAP revenue of $104.5 million, a 317.7% year-over-year increase largely attributable to recent M&A activity.
  • Pro forma same-store sales increased 22% year-over-year, while wholesale revenue rose 55% year-over-year; excluding Minnesota, same-store sales increased 11.3%.
  • Vireo announced pending acquisitions of Eaze, Schwazze retail assets, and PharmaCann assets in Colorado, alongside a non-binding MOU for Hawthorne.
  • The company concluded Q4 with $122.5 million in cash, signaling continued appetite for acquisitions.

The big picture

Vireo Growth's rapid expansion through acquisitions signals a bet on consolidating the fragmented cannabis market. The company's revenue growth is heavily reliant on these deals, but the integration of multiple entities—each with its own operational and cultural nuances—presents a significant challenge. Vireo's strategy contrasts with a more organic growth model, and its success will depend on its ability to extract value from its expanded footprint and navigate the complex regulatory environment.

What we're watching

Integration Risk
The success of Vireo's aggressive acquisition strategy hinges on the ability to effectively integrate disparate operations and realize anticipated synergies, a process that carries significant execution risk.
Regulatory Headwinds
The non-binding nature of the Hawthorne MOU and the potential for evolving regulatory landscapes could impact the timing and ultimate closure of key deals.
Financial Leverage
While the company holds a substantial cash balance, continued acquisitive growth will likely increase Vireo's debt burden and require careful management of its capital structure.

Vireo to Acquire Hawthorne Gardening in Share-Based Deal

Event summary

  • Vireo Growth Inc. has entered into a non-binding Memorandum of Understanding (MOU) to acquire The Hawthorne Gardening Company from ScottsMiracle-Gro.
  • The acquisition will be structured as a share-based transaction, expected to close during the first fiscal quarter of 2026.
  • Chris Hagedorn, Executive Vice President of ScottsMiracle-Gro, is slated to join Vireo’s Board of Directors.
  • Hawthorne Gardening Company is a leading provider of nutrients, lighting, and other materials for indoor and hydroponic gardening in North America.

The big picture

This acquisition represents Vireo’s continued effort to consolidate its position within the cannabis ancillary market, specifically targeting the growing indoor and hydroponic gardening segment. ScottsMiracle-Gro’s divestiture suggests a strategic realignment, prioritizing its core business while seeking a partner with a strong operating platform in the cannabis space. The share-based structure indicates Vireo’s confidence in its long-term growth prospects and willingness to share equity in a significant deal.

What we're watching

Deal Certainty
The non-binding nature of the MOU introduces significant execution risk; the parties must now negotiate definitive agreements, which could be subject to change or termination.
Integration Risk
Successfully integrating Hawthorne’s operations and product lines into Vireo’s existing structure will be crucial to realizing the anticipated benefits of the acquisition, and potential cultural clashes should be monitored.
Strategic Shift
ScottsMiracle-Gro’s decision to transition Hawthorne to an equity participation arrangement signals a potential shift in its exposure to the cannabis sector, and Vireo’s ability to capitalize on this change will be key.

Vireo Acquires Schwazze Notes at Discount, Bolstering Stake

Event summary

  • Vireo Growth Inc. is acquiring approximately $2.6 million in outstanding senior secured convertible notes of Schwazze from third-party noteholders.
  • The acquisition will be priced at a discount, with Vireo paying approximately $1.6 million.
  • The consideration will be paid in subordinate voting shares at $0.54 per share, totaling approximately 89% of Schwazze's outstanding notes.
  • The transaction is expected to close later this month, subject to customary approvals.

The big picture

Vireo's acquisition of Schwazze's convertible notes at a significant discount underscores the ongoing financial challenges within the cannabis sector. This move allows Vireo to increase its influence over Schwazze, potentially positioning it to benefit from any future turnaround, but also exposes it to the risks associated with a struggling entity. The deal highlights a trend of strategic maneuvering and asset consolidation as companies navigate a challenging regulatory and economic landscape.

What we're watching

Share Dilution
The issuance of subordinate voting shares to fund the acquisition will dilute existing shareholders, and the market will scrutinize whether the strategic benefits justify the increased share count.
Schwazze's Health
Vireo’s increased stake in Schwazze signals a continued belief in the company's potential, but the underlying financial health of Schwazze remains a key risk factor given the discounted note acquisition price.
Conversion Dynamics
The terms of the convertible notes and Vireo’s strategy for eventual conversion into equity will be critical to observe, as it will dictate Vireo’s future ownership stake in Schwazze.
CID: 531